Equity
FOLD
Amicus Therapeutics (FOLD)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for FOLD to draw a line in its place.
- Mentions, 30 days
- 1
Have Amicus Therapeutics (FOLD) insiders bought or sold shares recently?
FOLD has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 27 April 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Mar 2026 | Campbell Bradley LPresident and CEO | Sell | 22,500 | 323K USD |
| 20 Jan 2026 | Campbell Bradley LPresident and CEO | Sell | 75,000 | 1.1M USD |
| 19 Dec 2025 | Clark David MichaelChief People Officer | Sell | 25,642 | 363K USD |
| 15 Dec 2025 | Campbell Bradley LPresident and CEO | Sell | 77,926 | 846K USD |
| 15 Dec 2025 | Clark David MichaelChief People Officer | Sell | 25,643 | 282K USD |
| 01 Dec 2025 | Campbell Bradley LPresident and CEO | Sell | 14,587 | 146K USD |
| 26 Nov 2025 | Rosenberg EllenChief Legal Officer | Sell | 23,621 | 236K USD |
| 25 Nov 2025 | Rosenberg EllenChief Legal Officer | Sell | 36,000 | 360K USD |
| 24 Nov 2025 | Campbell Bradley LPresident and CEO | Sell | 14,587 | 147K USD |
| 24 Nov 2025 | Clark David MichaelChief People Officer | Sell | 25,643 | 259K USD |
| 24 Nov 2025 | Castelli JeffChief Development Officer | Sell | 76,158 | 774K USD |
| 24 Nov 2025 | Rosenberg EllenChief Legal Officer | Sell | 36,000 | 362K USD |
| Sold | 13 open-market sales | 478,950 | $5.41M |
Showing the 12 most recent of 13 open-market trades in this window. The figures above count all of them.
33 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 27 Apr 2026 | WHEELER CRAIG ADirector | Other | 84,631 | 1.2M USD |
| 27 Apr 2026 | MCGLYNN MARGARET GDirector | Other | 94,631 | 1.4M USD |
| 27 Apr 2026 | WHITMAN BURKE WDirector | Other | 118,598 | 1.7M USD |
| 27 Apr 2026 | SBLENDORIO GLENNDirector | Other | 142,564 | 2.1M USD |
| 27 Apr 2026 | ROBERTS EIRYDirector | Other | 76,275 | 1.1M USD |
| 27 Apr 2026 | Bleil Lynn DorseyDirector | Other | 113,941 | 1.7M USD |
| 27 Apr 2026 | Kelly Michael AaronDirector | Other | 72,468 | 1.1M USD |
| 27 Apr 2026 | RAAB MICHAELDirector | Other | 115,857 | 1.7M USD |
| 27 Apr 2026 | Prout SamanthaChief Accounting Officer | Other | 125,951 | 1.8M USD |
| 27 Apr 2026 | Castelli JeffChief Development Officer | Other | 427,089 | 6.2M USD |
| 27 Apr 2026 | Clark David MichaelChief People Officer | Other | 221,811 | 3.2M USD |
| 27 Apr 2026 | Rosenberg EllenChief Legal Officer | Other | 478,898 | 6.9M USD |
Showing the 12 most recent of 33 compensation filings in this window. The figures above count all of them.
Which funds hold Amicus Therapeutics (FOLD)?
0 of the 45 institutional funds we track reported a Amicus Therapeutics position for the quarter ended 30 Jun 2026; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Exited | |||
| Balyasny Asset Management | Exited | |||
| Citadel Advisors | Exited | |||
| D. E. Shaw & Co. | Exited | |||
| GAMCO Investors | Exited | |||
| Man Group | Exited | |||
| Marshall Wace | Exited | |||
| Millennium Management | Exited | |||
| Point72 Asset Management | Exited | |||
| Renaissance Technologies | Exited |
Have members of Congress traded Amicus Therapeutics (FOLD)?
The most recent congressional trade disclosed in Amicus Therapeutics is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 10 Apr 2023 | Daniel S. Goldmanhouse · Democrat–NY | Sale | 1K USD–15K USD | 39 days |
What has been filed or recorded for Amicus Therapeutics (FOLD)?
The filings we hold for Amicus Therapeutics, newest first: 6 quarterly earnings reports and 2 annual reports, the latest dated 31 Dec 2025. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.09 USD | |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.06 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.08 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.07 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.18 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.02 USD | |
| 30 Jun 2024 | Quarterly earnings | Q2 2024 reported | EPS −0.05 USD | |
| 31 Mar 2024 | Quarterly earnings | Q1 2024 reported | EPS −0.16 USD |
What is Reddit saying about Amicus Therapeutics (FOLD)?
Reddit mentioned FOLD 1 times in the 30 days to 8 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 1Communities 1
How often is Amicus Therapeutics (FOLD) mentioned on Reddit?
Share ↗
Where Amicus Therapeutics (FOLD) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.06 |
Amicus Therapeutics (FOLD): frequently asked questions
Have Amicus Therapeutics insiders bought or sold shares recently?
No Amicus Therapeutics insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 27 Apr 2026 (SEC Form 4). See Insiders
Which funds own Amicus Therapeutics?
0 of the 45 funds we track reported a Amicus Therapeutics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Balyasny Asset Management and Citadel Advisors. See Funds
Have members of Congress traded Amicus Therapeutics?
Yes. 1 trade in Amicus Therapeutics appears in the congressional disclosures we hold: a sale by Daniel S. Goldman (House, NY) dated 10 Apr 2023, filed 19 May 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Amicus Therapeutics last report earnings?
Amicus Therapeutics last reported earnings on 31 Dec 2025 for FY 2025, with EPS of −0.09 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Amicus Therapeutics?
Amicus Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARXBRL company facts
- SEC EDGARreported earnings figures and scheduled report dates
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Amicus_Therapeutics